Perspective Therapeutics Inc. (NYSE AMERICAN: CATX) Stock Information | RedChip

Perspective Therapeutics Inc. (NYSE AMERICAN: CATX)


$3.3700
-0.1600 ( -3.16% ) 596.3K

Perspective Therapeutics Inc is a medical technology and radiopharmaceutical company that is pioneering various treatment applications for cancers throughout the body. The Company has a proprietary technology that utilizes the alpha emitting isotope 212Pb to deliver powerful radiation specifically to cancer cells via specialized targeting peptides.

Market Data


Open


$3.3700

Previous close


$3.5300

Volume


596.3K

Market cap


$227.77M

Day range


$3.3150 - $3.5280

52 week range


$2.7000 - $19.0500

SEC Filings


Form Type Description Pages Date
10-k Annual reports 124 Mar 28, 2024
8-k 8K-related 16 Mar 28, 2024
8-k 8K-related 14 Mar 25, 2024
8-k 8K-related 117 Mar 19, 2024
4 Insider transactions 1 Mar 08, 2024
8-k 8K-related 103 Mar 08, 2024
8-k 8K-related 22 Mar 06, 2024
8-k 8K-related 104 Feb 05, 2024
4 Insider transactions 1 Feb 01, 2024
3 Insider transactions 1 Feb 01, 2024

Latest News